NCT02863055 2025-09-19
NEMO
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
Clinical Trials
5 trialsNCT02808247 2021-09-20
ANITA
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT01788982 2020-07-31
Nintedanib(BIBF1120) in Thyroid Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT01225887 2017-10-09
Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer
GOG Foundation
Phase 2 Completed
NCT02856867 2017-05-09
MEGAN
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Withdrawn